MP 20XAlternative Names: MP-20X
Latest Information Update: 20 Jun 2015
At a glance
- Originator Medipure Holdings
- Class Anxiolytics; Cannabinoids
- Mechanism of Action Cannabinoid receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Anxiety disorders